INCOME TAXES

12 Months Ended

Dec. 31, 2022

Income Tax Disclosure [Abstract]

INCOME TAXES

INCOME TAXES

Income (Loss) Before Income Taxes

The consolidated income (loss) before income taxes for 2022, 2021, and 2020 consists of the following (in thousands):

	Years Ended December 31,
	2022		2021		2020
Domestic	$	144,443	$	5,426	$	(110,049)
Foreign	1,992		(4,136)		835
Total income (loss) before income taxes	$	146,435	$	1,290	$	(109,214)

Income Tax Expense (Benefit)

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was enacted and signed into law in response to the COVID-19 global pandemic. Certain provisions of the CARES Act had a significant impact on the effective tax rate, income tax payable, and deferred income tax positions of the Company for 2020. The CARES Act permits net operating losses (“NOLs”) incurred in tax years 2020, 2019, and 2018 to offset 100% of taxable income and be carried-back to each of the five preceding taxable years to generate a refund of previously paid income taxes. The Company evaluated the impact of the CARES Act during the year ended December 31, 2020 and recorded an income tax receivable of $13.2 million for the benefit of carrying back the NOL for the year ended December 31, 2020. As the Company was carrying the losses back to years beginning before January 1, 2018, the receivables were recorded at the previous 35% federal tax rate rather than the current statutory rate of 21%.

The consolidated income tax expense (benefit) for 2022, 2021, and 2020 consists of the following components (in thousands):

	Years Ended December 31,
	2022		2021		2020
Current
Federal	$	34,490	$	8,449	$	(15,190)
State	6,468		(1,098)		(2,072)
Foreign	321		922		444
	41,279		8,273		(16,818)
Deferred
Federal	(5,911)		(9,423)		7,918
State	(1,703)		1,310		(2,959)
Foreign	—		(34)		57
	(7,614)		(8,147)		5,016
Total consolidated expense (benefit)	$	33,665	$	126	$	(11,802)

The following table provides a reconciliation of differences from the U.S. Federal statutory rates as follows (in thousands):

	Years Ended December 31,
	2022		2021		2020
Pretax book income (loss)	$	146,435	$	1,290	$	(109,214)
Federal tax expense (benefit) at applicable statutory rate	30,751		271		(22,935)
State and local income taxes (net of federal benefit)	3,669		212		(4,948)
Rate differential	—		—		(5,004)
Impairment and divestiture	—		870		20,111
Tax credits	(2,422)		(2,065)		—
Nondeductible officer compensation	977		390		490
Compensation expense	1,013		964		1,070
Other	(323)		(516)		(586)
Total income tax expense (benefit)	$	33,665	$	126	$	(11,802)

Deferred Taxes

The Company’s deferred income taxes are primarily due to temporary differences between financial and income tax reporting for incentive compensation, depreciation of property, plant and equipment, amortization of intangibles, and other accrued liabilities.

Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Companies are required to assess whether valuation allowances should be established against their deferred tax assets based on the consideration of all available evidence, both positive and negative, using a “more likely than not” standard. In making such judgments, significant weight is given to evidence that can be objectively verified.

The Company assesses, on a quarterly basis, the realizability of its deferred tax assets by evaluating all available evidence, both positive and negative, including: (1) the cumulative results of operations in recent years, (2) the nature of recent losses, if applicable, (3) estimates of future taxable income, (4) the length of net operating loss carryforwards (“NOLs”) and (5) the uncertainty associated with a possible change in ownership, which imposes an annual limitation on the use of these carryforwards.

As of December 31, 2022 and 2021, the Company retained a valuation allowance of $0.8 million and $1.2 million, respectively, against deferred tax assets related to various state and local NOLs that are subject to restrictive rules for future utilization.

As of December 31, 2022 and 2021, the Company had no U.S. federal tax NOLs. The Company incurred a net loss in 2020 and fully utilized that loss in carrybacks. The Company has various multi-state income tax NOLs aggregating approximately $68.6 million which will expire between 2023 and 2043, if unused.

The components of deferred tax assets and deferred tax liabilities as of December 31, 2022 and 2021 were as follows (in thousands):

	December 31,
	2022		2021
Deferred tax assets
Tax credits and loss carryforwards	$	2,929	$	800
Accrued liabilities	5,965		5,764
Incentive compensation	6,960		8,012
Operating lease assets	5,878		2,875
Research expenditure amortization	7,739		—
Other	6,560		6,098
	36,031		23,549
Deferred tax liabilities
Property, plant and equipment	(22,991)		(22,344)
Intangibles	(30,188)		(28,748)
Operating lease liabilities	(5,878)		(2,875)
Other	(3,957)		(4,364)
	(63,014)		(58,331)
Net deferred tax liability before valuation allowances and reserves	(26,983)		(34,782)
Valuation allowances	(775)		(1,237)
Net deferred tax liability	$	(27,758)	$	(36,019)

Tax Reserves

The Company’s policy with respect to interest and penalties associated with reserves or allowances for uncertain tax positions is to classify such interest and penalties in Income tax expense (benefit) on the Consolidated Statements of Operations. As of December 31, 2022 and 2021, the total amount of unrecognized income tax benefits, which are included in either Other noncurrent liabilities or Deferred income taxes in the Company’s Consolidated Balance Sheets, was approximately $2.4 million and $2.3 million, respectively, including interest and penalties, all of which, if recognized, would impact the effective income tax rate of the Company. As of December 31, 2022 and 2021, the Company had recorded a total of $0.9 million and $0.8 million, respectively, of accrued interest and penalties related to uncertain tax positions. The Company expects no significant changes to the facts and circumstances underlying its reserves and allowances for uncertain income tax positions as reasonably possible during the next 12 months. As of December 31, 2022, the Company is subject to unexpired statutes of limitation for U.S. federal income taxes for the years 2019 through 2021. The Company is also subject to unexpired statutes of limitation for Indiana state income taxes for the years 2019 through 2021.